Improving persistence and adherence to osteoporosis treatment: a challenge to solve

被引:2
|
作者
Alarcon, T. [1 ,2 ,3 ,5 ]
Gonzalez-Montalvo, J. I. [1 ,2 ,3 ]
Martin-Vega, A. [4 ]
Gotor, P. [1 ,3 ]
机构
[1] La Paz Univ Hosp, Acute Orthogeriatr Unit, Dept Geriatr, Madrid, Spain
[2] Univ Autonoma Madrid, Sch Med, Madrid, Spain
[3] La Paz Univ Hosp, IdiPAZ, Madrid, Spain
[4] La Paz Univ Hosp, Dept Clin Management, Madrid, Spain
[5] Hosp Univ La Paz, Serv Geriatr, Paseo Castellana 261, Madrid 28046, Spain
关键词
Phone Call; Osteoporosis Treatment; Standard Clinical Practice; Reminder Call; Daily Vitamin;
D O I
10.1007/s00198-015-3323-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1275 / 1276
页数:2
相关论文
共 50 条
  • [1] Improving persistence and adherence to osteoporosis treatment: a challenge to solve
    T. Alarcón
    J. I. González-Montalvo
    A. Martín-Vega
    P. Gotor
    Osteoporosis International, 2016, 27 : 1275 - 1276
  • [2] Improving adherence to and persistence with oral therapy of osteoporosis
    M. L. Bianchi
    P. Duca
    S. Vai
    G. Guglielmi
    R. Viti
    C. Battista
    A. Scillitani
    S. Muscarella
    G. Luisetto
    V. Camozzi
    R. Nuti
    C. Caffarelli
    S. Gonnelli
    C. Albanese
    V. De Tullio
    G. Isaia
    P. D’Amelio
    F. Broggi
    M. Croci
    Osteoporosis International, 2015, 26 : 1629 - 1638
  • [3] Improving adherence to and persistence with oral therapy of osteoporosis
    Bianchi, M. L.
    Duca, P.
    Vai, S.
    Guglielmi, G.
    Viti, R.
    Battista, C.
    Scillitani, A.
    Muscarella, S.
    Luisetto, G.
    Camozzi, V.
    Nuti, R.
    Caffarelli, C.
    Gonnelli, S.
    Albanese, C.
    De Tullio, V.
    Isaia, G.
    D'Amelio, P.
    Broggi, F.
    Croci, M.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 (05) : 1629 - 1638
  • [4] PERSISTENCE AND ADHERENCE TO DENOSUMAB FOR THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    Parrotta, A.
    Muccari, G.
    De Luca, E.
    Gallo, G.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S287 - S288
  • [5] Adherence and persistence associated with the pharmacologic treatment of osteoporosis in a managed care setting
    Downey, Timothy W.
    Foltz, Susan H.
    Boccuzzi, Stephen J.
    Omar, Mohamed A.
    Kahler, Kristijan H.
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (06) : 570 - 575
  • [6] A new look at osteoporosis outcomes: The influence of treatment, compliance, persistence, and adherence
    Badamgarav, Enkhe
    Fitzpatrick, Lorraine A.
    MAYO CLINIC PROCEEDINGS, 2006, 81 (08) : 1009 - 1012
  • [7] Adherence to and persistence with zoledronic acid treatment for osteoporosis—reasons for early discontinuation
    Anna Spångeus
    Simon Johansson
    Mischa Woisetschläger
    Archives of Osteoporosis, 2020, 15
  • [8] Improving treatment adherence in kidney transplantation: A major challenge
    Kessler, Michele
    NEPHROLOGIE & THERAPEUTIQUE, 2014, 10 (03): : 145 - 150
  • [9] Adherence to and persistence with zoledronic acid treatment for osteoporosis-reasons for early discontinuation
    Spangeus, Anna
    Johansson, Simon
    Woisetschlager, Mischa
    ARCHIVES OF OSTEOPOROSIS, 2020, 15 (01)
  • [10] The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: A randomized controlled
    Clowes, JA
    Peel, NFA
    Eastell, R
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03): : 1117 - 1123